PanDrugs
PanDrugs is a method to prioritize anticancer drug treatments according to individual genomic data. PanDrugs current version integrates data from 24 primary sources and supports 56297 drug-target associations obtained from 4804 genes and 9092 unique compounds.
Description
More detailed information about this field from each metasource.
PanDrugs is a method to prioritize anticancer drug treatments according to individual genomic data. PanDrugs current version integrates data from 24 primary sources and supports 56297 drug-target associations obtained from 4804 genes and 9092 unique compounds.
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:24:37.972276
Webpage:
https://www.pandrugs.org/Webpage
More detailed information about this field from each metasource.
Licence:
Name: GPL-3.0Licence name
More detailed information about this field from each metasource.
Publications:
Publications
More detailed information about this field from each metasource.
PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data
PMID: 29848362
metasource: bio.tools
version: extracted_at: 2022-11-04T11:24:37.972276
Publications
More detailed information about this field from each metasource.
PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data
PMID: 29848362
metasource: bio.tools
version: extracted_at: 2022-11-04T11:24:37.972276
-
PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data
PubMed citations: 25.
25 articles citing: PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data
Navigating Multi-Scale Cancer Systems Biology Towards Model-Driven Clinical Oncology and Its Applications in Personalized Therapeutics. PMID:34900668
Clinical Value of NGS Genomic Studies for Clinical Management of Pediatric and Young Adult Bone Sarcomas. PMID:34771600
A Personalized Therapeutics Approach Using an In Silico Drosophila Patient Model Reveals Optimal Chemo- and Targeted Therapy Combinations for Colorectal Cancer. PMID:34336681
Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP). PMID:34302033
Proteomics and Drug Repurposing in CLL towards Precision Medicine. PMID:34298607
An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia. PMID:34171302
Knowledge bases and software support for variant interpretation in precision oncology. PMID:33971666
Microbial Genomics as a Catalyst for Targeted Antivirulence Therapeutics. PMID:33928102
Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma. PMID:33777535
Patient-Specific Network for Personalized Breast Cancer Therapy with Multi-Omics Data. PMID:33670375
The tumor therapy landscape of synthetic lethality. PMID:33627666
GMIEC: a shiny application for the identification of gene-targeted drugs for precision medicine. PMID:32912170
Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns. PMID:32907621
OncoPDSS: an evidence-based clinical decision support system for oncology pharmacotherapy at the individual level. PMID:32770988
Turning genome-wide association study findings into opportunities for drug repositioning. PMID:32670504
A user guide for the online exploration and visualization of PCAWG data. PMID:32636365
Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer. PMID:32244556
Precision oncology for gallbladder cancer: insights from genetic alterations and clinical practice. PMID:31700903
The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data. PMID:31655559
In Silico Drug Prescription for Targeting Cancer Patient Heterogeneity and Prediction of Clinical Outcome. PMID:31540260
Cancer Informatics in 2018: The Mysteries of the Cancer Genome Continue to Unravel, Deep Learning Approaches the Clinic, and Passive Data Collection Demonstrates Utility. PMID:31419838
vulcanSpot: a tool to prioritize therapeutic vulnerabilities in cancer. PMID:31173067
IPCT: Integrated Pharmacogenomic Platform of Human Cancer Cell Lines and Tissues. PMID:30813377
PreMedKB: an integrated precision medicine knowledgebase for interpreting relationships between diseases, genes, variants and drugs. PMID:30407536
Atrial Structural Remodeling Gene Variants in Patients with Atrial Fibrillation. PMID:30276209
Tags:
Tags
More detailed information about this field from each metasource.
oncology
metasource: bio.tools
version: extracted_at: 2022-11-04T11:24:37.972276
genomics
metasource: bio.tools
version: extracted_at: 2022-11-04T11:24:37.972276
dna mutation
metasource: bio.tools
version: extracted_at: 2022-11-04T11:24:37.972276
pharmacogenomics
metasource: bio.tools
version: extracted_at: 2022-11-04T11:24:37.972276
Tags
More detailed information about this field from each metasource.
oncology
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:24:37.972276
genomics
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:24:37.972276
dna mutation
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:24:37.972276
pharmacogenomics
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:24:37.972276
oncology genomics dna mutation pharmacogenomics
Need help integrating and/or managing biomedical data?